<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Effect of solute carrier organic anion transporter 1B1 (SLCO1B1) and multiple drug resistance 1((MDR1) genotypes on lipid profile of atorvastatin - treated hypercholesterolemic Egyptian patients</title>
  </titleInfo>
  <titleInfo type="alternative">
    <title>على صورة الدهون بالدم لمرضى مصريين مصابين بارتفاع الكوليسترول بالدم و يعالجون بعقار (أتورفاستاتين( (MDR1) و (SLCO1B1)تأثير الاشكال الجينية لجينى</title>
  </titleInfo>
  <name type="personal">
    <namePart>Mona Farag Shabana</namePart>
    <role>
      <roleTerm authority="marcrelator" type="text">creator</roleTerm>
    </role>
  </name>
  <name type="personal">
    <namePart>Amal Anwar Mishriki</namePart>
    <role>
      <roleTerm type="text">Supervisor</roleTerm>
    </role>
  </name>
  <name type="personal">
    <namePart>Ghada Abdelzaher Hashim</namePart>
    <role>
      <roleTerm type="text">Supervisor</roleTerm>
    </role>
  </name>
  <name type="personal">
    <namePart>Sameh Wadie Ghali Bakhoum</namePart>
    <role>
      <roleTerm type="text">Supervisor</roleTerm>
    </role>
  </name>
  <typeOfResource>text</typeOfResource>
  <genre authority="marc">theses</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">ua</placeTerm>
    </place>
    <place>
      <placeTerm type="text">Cairo</placeTerm>
    </place>
    <publisher>Mona Farag Shabana</publisher>
    <dateIssued>2013</dateIssued>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="marcform">print</form>
    <extent>110P. :  charts , facsimiles ;  25cm</extent>
  </physicalDescription>
  <abstract>The aim of the present study was to evaluate the effect of genetic polymorphisms of SLCO1B1 and MDR1 on the pharmacodynamics of atorvastatin which is the degree of improvement in the lipid profile of patients receiving atorvastatin . We studied 50 patients receiving atorvastatin in a dose of 40 mg once per day for a period of 4 weeks . We used the specific primers for restriction fragment length polymorphism</abstract>
  <targetAudience authority="marctarget">specialized</targetAudience>
  <note type="statement of responsibility">Mona Farag Shabana ; Supervised Amal Anwar Mishriki , Ghada Abdelzaher Hashim , Sameh Wadie Ghali Bakhoum</note>
  <note>Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Pharmacology</note>
  <note>Issued also as CD</note>
  <subject>
    <topic>Atorvastatin </topic>
  </subject>
  <subject>
    <topic>Hypercholesterolemia </topic>
  </subject>
  <subject>
    <topic>MDRI </topic>
  </subject>
  <identifier type="uri">http://172.23.153.220/th.pdf</identifier>
  <location>
    <url>http://172.23.153.220/th.pdf</url>
  </location>
  <recordInfo>
    <recordContentSource authority="marcorg">EG-GiCUC</recordContentSource>
    <recordCreationDate encoding="marc">130601</recordCreationDate>
    <recordChangeDate encoding="iso8601">20250223030836.0</recordChangeDate>
    <languageOfCataloging>
      <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
    </languageOfCataloging>
  </recordInfo>
</mods>
